1,601 reports of this reaction
3.4% of all LINEZOLID reports
#4 most reported adverse reaction
ANAEMIA is the #4 most commonly reported adverse reaction for LINEZOLID, manufactured by Hp Halden Pharma AS. There are 1,601 FDA adverse event reports linking LINEZOLID to ANAEMIA. This represents approximately 3.4% of all 47,534 adverse event reports for this drug.
Patients taking LINEZOLID who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is moderately reported among LINEZOLID users, representing a notable but not dominant share of adverse events.
In addition to anaemia, the following adverse reactions have been reported for LINEZOLID:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 1,601 FDA reports for LINEZOLID. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 3.4% of all adverse event reports for LINEZOLID, making it a notable side effect.
If you experience anaemia while taking LINEZOLID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.